Literature DB >> 33768671

Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis.

Jie Mei1,2,3,4, Huixiang Tian5, Hsuan-Shun Huang6, Che-Fang Hsu6, Yuligh Liou1,2, Nayiyuan Wu7, Wei Zhang1,2,3,4, Tang-Yuan Chu6,8,9.   

Abstract

High-grade serous carcinoma (HGSC) is the most common and malignant histological type of epithelial ovarian cancer, the origin of which remains controversial. Currently, the secretory epithelial cells of the fallopian tube are regarded as the main origin and the ovarian surface epithelial cells as a minor origin. In tubal epithelium, these cells acquire TP53 mutations and expand to a morphologically normal 'p53 signature' lesion, transform to serous tubal intraepithelial carcinoma and metastasize to the ovaries and peritoneum where they develop into HGSC. This shifting paradigm of the main cell of origin has revolutionarily changed the focus of HGSC research. Various cell lines have been derived from the two cellular origins by acquiring immortalization via overexpression of hTERT plus disruption of TP53 and the CDK4/RB pathway. Malignant transformation was achieved by adding canonical driver mutations (such as gain of CCNE1) revealed by The Cancer Genome Atlas or by noncanonical gain of YAP and miR181a. Alternatively, because of the extreme chromosomal instability, spontaneous transformation can be achieved by long passage of murine immortalized cells, whereas in humans, it requires ovulatory follicular fluid, containing regenerating growth factors to facilitate spontaneous transformation. These artificially and spontaneously transformed cell systems in both humans and mice have been widely used to discover carcinogens, oncogenic pathways and malignant behaviours in the development of HGSC. Here, we review the origin, aetiology and carcinogenic mechanism of HGSC and comprehensively summarize the cell models used to study this fatal cancer having multiple cells of origin and overt genomic instability.
© 2021 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.

Entities:  

Year:  2021        PMID: 33768671     DOI: 10.1111/cpr.13029

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  7 in total

1.  Ovulation Enhances Intraperitoneal and Ovarian Seedings of High-Grade Serous Carcinoma Cells Originating from the Fallopian Tube: Confirmation in a Bursa-Free Mouse Xenograft Model.

Authors:  Che-Fang Hsu; Vaishnavi Seenan; Liang-Yuan Wang; Tang-Yuan Chu
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

2.  Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation.

Authors:  Hsuan-Shun Huang; Pao-Chu Chen; Sung-Chao Chu; Ming-Hsun Lee; Chi-Ya Huang; Tang-Yuan Chu
Journal:  Neoplasia       Date:  2021-10-21       Impact factor: 5.715

3.  Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC).

Authors:  Chetan C Oturkar; Nishant Gandhi; Pramod Rao; Kevin H Eng; Austin Miller; Prashant K Singh; Emese Zsiros; Kunle O Odunsi; Gokul M Das
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.575

Review 4.  Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics.

Authors:  Ikuo Konishi; Kaoru Abiko; Takuma Hayashi; Koji Yamanoi; Ryusuke Murakami; Ken Yamaguchi; Junzo Hamanishi; Tsukasa Baba; Noriomi Matsumura; Masaki Mandai
Journal:  J Gynecol Oncol       Date:  2022-09       Impact factor: 4.756

5.  Possible Association of Hysterectomy Accompanied with Opportunistic Salpingectomy with Early Menopause: A Retrospective Cohort Study.

Authors:  Pei-Chen Chen; Pei-Chen Li; Dah-Ching Ding
Journal:  Int J Environ Res Public Health       Date:  2022-09-20       Impact factor: 4.614

6.  Analyzing cancer gene expression data through the lens of normal tissue-specificity.

Authors:  H Robert Frost
Journal:  PLoS Comput Biol       Date:  2021-06-18       Impact factor: 4.475

7.  PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer.

Authors:  Emily Lee; Sarah Szvetecz; Ryan Polli; Angelo Grauel; Jayson Chen; Joyce Judge; Smita Jaiswal; Rie Maeda; Stephanie Schwartz; Bernd Voedisch; Mateusz Piksa; Chietara Japutra; Lingheswar Sadhasivam; Yiqin Wang; Ana Carrion; Sinan Isim; Jinsheng Liang; Thomas Nicholson; Hong Lei; Qing Fang; Michelle Steinkrauss; Dana Walker; Joel Wagner; Viviana Cremasco; Hui Qin Wang; Giorgio G Galli; Brian Granda; Keith Mansfield; Quincey Simmons; Andrew Anh Nguyen; Nicole Vincent Jordan
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.